| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
73.28 |
64.11 |
43.61 |
83.28 |
77.59 |
|
| Diluted EPS (Rs.) |
73.25 |
64.06 |
43.61 |
83.28 |
77.59 |
|
| Cash EPS (Rs.) |
84.31 |
74.35 |
54.27 |
97.94 |
90.53 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
289.21 |
270.17 |
256.94 |
369.15 |
331.80 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
289.21 |
270.17 |
256.94 |
369.15 |
331.80 |
|
| Dividend / Share(Rs.) |
28.00 |
51.00 |
7.00 |
9.50 |
9.50 |
|
| Revenue from Operations/Share (Rs.) |
344.80 |
314.30 |
269.99 |
365.83 |
312.66 |
|
| PBDIT/Share (Rs.) |
105.67 |
97.82 |
65.85 |
120.05 |
117.36 |
|
| PBIT/Share (Rs.) |
94.51 |
87.36 |
55.80 |
105.96 |
104.54 |
|
| PBT/Share (Rs.) |
94.14 |
86.82 |
55.39 |
104.90 |
103.75 |
|
| Net Profit/Share (Rs.) |
73.15 |
63.89 |
44.22 |
83.85 |
77.70 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
30.64 |
31.12 |
24.39 |
32.81 |
37.53 |
|
| PBIT Margin (%) |
27.40 |
27.79 |
20.66 |
28.96 |
33.43 |
|
| PBT Margin (%) |
27.30 |
27.62 |
20.51 |
28.67 |
33.18 |
|
| Net Profit Margin (%) |
21.21 |
20.32 |
16.37 |
22.92 |
24.85 |
|
| Return on Networth / Equity (%) |
25.29 |
23.64 |
17.21 |
22.71 |
23.41 |
|
| Return on Capital Employed (%) |
30.82 |
30.76 |
20.75 |
27.47 |
30.13 |
|
| Return on Assets (%) |
20.13 |
19.14 |
12.97 |
19.04 |
19.12 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.99 |
0.93 |
0.84 |
0.86 |
0.83 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.62 |
3.88 |
2.81 |
4.38 |
3.56 |
|
| Quick Ratio (X) |
2.58 |
2.80 |
2.06 |
3.03 |
2.33 |
|
| Inventory Turnover Ratio (X) |
1.19 |
1.38 |
1.33 |
1.22 |
1.32 |
|
| Dividend Payout Ratio (NP) (%) |
38.14 |
79.55 |
16.05 |
11.42 |
12.26 |
|
| Dividend Payout Ratio (CP) (%) |
33.09 |
68.35 |
13.08 |
9.77 |
10.53 |
|
| Earnings Retention Ratio (%) |
61.86 |
20.45 |
83.95 |
88.58 |
87.74 |
|
| Cash Earnings Retention Ratio (%) |
66.91 |
31.65 |
86.92 |
90.23 |
89.47 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
32,773.18 |
28,215.33 |
15,005.16 |
15,386.30 |
15,440.33 |
|
| EV/Net Operating Revenue (X) |
7.58 |
7.11 |
4.40 |
4.90 |
5.68 |
|
| EV/EBITDA (X) |
24.74 |
22.83 |
18.03 |
14.93 |
15.13 |
|
| MarketCap/Net Operating Revenue (X) |
7.59 |
7.12 |
4.48 |
4.95 |
5.74 |
|
| Retention Ratios (%) |
61.85 |
20.44 |
83.94 |
88.57 |
87.73 |
|
| Price/BV (X) |
9.05 |
8.28 |
4.71 |
4.90 |
5.40 |
|
| Price/Net Operating Revenue |
7.59 |
7.12 |
4.48 |
4.95 |
5.74 |
|
| Earnings Yield |
0.03 |
0.03 |
0.04 |
0.05 |
0.04 |
|
Source : Dion Global Solutions Limited
